Home on the Web
 for active people,
their families & friends.

 

Home
What's New & To Do
World News
Your Home Office
Editorial
Healthy Living
Contributor's Columns
Interests
Knowledge & Learning
Shopping

Travel
Archived Articles
Car Rentals
Links
Newsletters
Search Engines
Feedback Form
  

 

Prostate Article 2

Join the 50plus-feeling30 mailing list
Email:

 

Sponsoring Organisation

The
Nutri Centre
UK

 

Focus on the Prostate Gland ... 2

Flower Therapy: Proven Treatment for Enlarged Prostate Gains New Ground

Benign Prostatic Hyperplasia (BPH), commonly known as enlarged prostate, is the silent disease among men. Afflicting over 10 million American males, BPH is a painful and embarrassing ailment. The disease begins with an increased need to urinate (often at night), frequently coupled with difficulty in doing so. This leads to general pain and discomfort in the groin region, a feeling of residual urine in the bladder even after voiding and, in serious cases, may result in the complete inability to urinate.

Why does this happen? Well, no one is exactly sure. Located around the urethra at the point of the bladder, the prostate’s main function is to help produce semen. As a man ages, the prostate grows, eventually clamping down on the urethra and obstructing the flow of urine from the bladder.

Mainline treatments range from medications (with unpleasant and harmful side effects) to, in advanced cases, various forms of surgery – which can result in permanent impotence. This does not have to be so.

The Prostabrit solution

Used successfully for over 30 years in Europe and Asia, Prostabrit is a combination of extracts from the pollen of eight different plants: rye, maize, timothy, hazel, pine, oxeye daisy, sallow and aspen. Discovered in Sweden almost half a century ago, this non-allergenic mixture has proven remarkably effective in the treatment of BPH.

In 1988, a double-blind, placebo-controlled study concluded that Prostabrit improved nocturia (excessive urination at night – the principle symptom of BPH) in 68.8% of the cases, as opposed to 37.2% of the placebo group. In regard to residual urine (urine that remains in the bladder), 54.7% of the Prostabrit group showed improvement, as compared with only 12.5% of the placebo.

A second double-blind, placebo-controlled study, published in 1990, mirrored these results. In it, Prostabrit was found to either eliminate or improve nocturia in 60% of the BPH patients tested. This compared with 30% of the subjects on the placebo. Even more impressive was the improvement in bladder emptying - 57% of the Prostabrit users vs. only 10% of the placebo group. All told, 60% of the Prostabrit patients reported an overall improvement in their BPH symptom, as compared with 29% in the placebo group.

Some naked truth from the nude mouse

Because of the strong placebo effect found in most clinical trials of patients with BPH, researchers devised a study to eliminate that bias. Human BPH tissue was transplanted onto 12 nude mice. The mice were then separated into three groups: the first remaining a control, the second receiving a silicon implant to stimulate the BPH tissue, and the third receiving the implant and Prostabrit. After six weeks, the tissue on the mice was examined, and the results were dramatic.

While the BPH tissue if the second group (which received the stimulation alone) grew, the tissue in the Prostabrit group shrank – even with the stimulation. The researchers concluded that Prostabrit is the first plant-derived drug to show a significant growth-inhibiting effect on human BPH tissue.

What does this mean for those who suffer from BPH? Simply put, users of Prostabrit can benefit from its proven ability to inhibit or reverse the growth of enlarged prostates.

"The Miracle of Prostabrit"

In 1998, Prostabrit received strong support from a prominent Georgetown University doctor. In his book, The Prostate Cure: The Revolutionary Natural Approach to Treating Enlarged Prostates, Harry Preuss,M.D., urged the use of Prostabrit for BPH patients. Devoting an entire chapter (titled, "The Miracle of Prostabrit") to the product, Preuss underscored the proven clinical effectiveness of the pollen extract, coupled with almost no side effects. Indeed, one study concluded that Prostabrit’s tolerance was 99% among users (the single reported side effect being rare upset stomach).

The researchers concluded that Prostabrit
is the first plant-derived drug to show a significant
growth-inhibiting effect on human BPH tissue.

According to Preuss, scientists have established three main beneficial components of Prostabrit’s activity: 

bulletIt acts as an anti-inflammatory, reducing swelling of the tissues of the prostate by inhibiting the formation of inflammatory chemicals. 
bulletIt acts as a smooth-muscle relaxant in the bladder and prostate. As a result, urine flows through the urethra unobstructed.
bulletIt blocks the production of DHT (the male hormone that stimulates BPH), and thus inhibits prostate growth.

After evaluating scores of medical tests and studies demonstrating the effectiveness of Prostabrit on BPH, Preuss concluded: 

"Taken all together, studies conducted by Ace Ashland [one of the developers of Posterity] and his staff, and by independent medical researchers around the world, Posterity, a standardised pollen extract, to be exceptionally effective in the treatment of BPH." 

The makers of Prostabrit recommend taking 4 tablets a day. For maximum success, begin taking Prostabrit in the early stages of BPH, as studies have shown it to be most effective in that period.

Prostate Article 1 Prostate Article 2 Prostate Article 3 Prostate Article 4 Prostate Article 5